America Great Health (AAGH)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 29, 2026, 4:00 PM EST
-80.00%
Market Cap 21.15K
Revenue (ttm) 391.74K
Net Income (ttm) -719.12K
Shares Out 21.15B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 528,865
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0180
Beta 6.40
RSI 40.42
Earnings Date Nov 28, 2025

About America Great Health

America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mike Wang
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol AAGH
Full Company Profile

Financial Performance

In fiscal year 2025, America Great Health's revenue was $391,743, an increase of 32.94% compared to the previous year's $294,670. Losses were -$719,119, -41.08% less than in 2024.

Financial Statements

News

There is no news available yet.